What's Wrong With American Drug Development
We have a policy to "do no harm," but instead we should be aiming to "do more good." For example, we could use a drug that might kill 2% of the people that take it, but 80% of the people who were otherwise going to die, would not live. That's a much better outcome, but we can't do it right now due to regulations.
We have the science and the manufacturing capacity to do it, but regulatory hurdles in America are preventing scientists from actually doing it. As a result, people do not have a choice to decide whether they want to use a certain drug or not.
Even Remdesivir, the drug that seems to be helping with Covid-19 and does not have any mortality associated with it, people cannot simply get it at the hospital.
On this episode
- Can We Measure The Response To Social Isolation Without Access To Government Data
- What Is Wrong With Our Covid-19 Response Strategy
- Should We Be Worried About The Anti-science Movement
- What Are We Missing With Testing For The Coronavirus Disease
- Will Coronavirus Be The End Of Trump's Presidency
- Why Is Media So Completely Inaccurate Today
- Do We Have Any Miracle Drugs To Treat Coronavirus
- Why Is Italy Having Such A Hard Time With Coronavirus
- What Is Herd Immunity And Why Is It Important
- How Is Facebook Similar To The Coronavirus
- Why Are We All Hiding From The Coronavirus
- What Can We Do To Improve Our Response To Viral Diseases Of The Future
- What's Wrong With American Drug Development
- What Are The Unintended Consequences Of Coronavirus Lockdown
- Why Is The Stock Market Crashing Due To The Virus
- What Is Next For Startups And Venture Capital